Induction is the first phase of treatment for leukemia, beginning immediately after diagnosis and typically lasting for 28 days. The goal of this critical phase is to induce remission quickly after diagnosis.
During this phase, common chemotherapy drugs include Daunorubicin, cytarabine, methotrexate, mercaptopurine, vincristine, PEG or Erwinia, and steroids like prednisone or dexamethasone. Patients also typically begin a regime of bactrim two days a week to help prevent infections.
Like other phases, the actual pace and mix of chemotherapy during induction depends on the risk group the patient is assigned to.